WallStSmart
KLRA

Kailera Therapeutics, Inc. Common Stock

NASDAQ: KLRA · HEALTHCARE · BIOTECHNOLOGY

$12.57
-5.28% today

Updated 2026-11-16

Market cap
$1.85B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.16
Dividend yield
—
52W range
$10 – $28
Volume
1.2M

Kailera Therapeutics, Inc. Common Stock (KLRA) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$12.57
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—

Financial forecast

Metric2025
Revenue$0.0B
EPS—
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.